Cash and cash equivalents of $261.3M as of December 31, 2025, provide expected cash runway at least into 2028.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADCT:
- ADC Therapeutics Ltd (ADCT) Q4 Earnings Cheat Sheet
- ADC Therapeutics Amends Royalty Deal, Issues New Warrants
- ADC Therapeutics announces amended HealthCare Royalty financing agreement
- ADC Therapeutics participates in a conference call with Cantor
- ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy